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Abstract
To provide tissue-specific and developmental characteristics of gene expression of rat heart uncoupling protein-2 (UCP2),
we investigated developmental alterations of UCPs mRNA expression in the heart and brown adipose tissue (BAT), and
examined possible up-regulators of heart UCP2 expression using in vitro studies. Heart UCP2 mRNA expression was low
during the early postnatal days followed by a rapid and significant increase in the 2nd postnatal week. Heart UCP3 mRNA
remained undetectable until the 2nd postnatal week when the expression reached a small but significant peak. BAT UCP1
mRNA was abundantly expressed in the neonate, but the expression rapidly decreased to the adult level. The studies using
cultured cardiomyocytes demonstrated that both 1038 M triiodothyronine and 1037 M isoproterenol, but not phenylephrine,
increased UCP2 mRNA expression. These results indicate that the sympathetic nervous system and/or thyroid hormones
may be involved in the up-regulation of heart UCP2 gene expression during postnatal development. The increase in postnatal
heart UCP2 may provide a key link between the postnatal energy shift and adaptation of rat pups to their novel
environment. ß 1999 Elsevier Science B.V. All rights reserved.
Keywords: Uncoupling protein-2; Development; Heart; L-Adrenoceptor; Triiodothyronine
1. Introduction
Uncoupling proteins (UCPs) are unique proteins
located in the inner mitochondrial membrane.
UCPs convert stored energy into heat [1,2] by trans-
porting fatty acid anions to dissipate a proton elec-
trochemical potential, uncoupled from ATP synthesis
[3]. Indeed, UCPs play a potentially important role
in determining metabolic e⁄ciency. UCP1, the ¢rst
uncoupling protein to be identi¢ed, is expressed ex-
clusively in brown adipose tissue (BAT), an impor-
tant site of energy expenditure in rodents [4]. In con-
trast to rodents, the abundance of BAT in large
mammals is limited [5] and, therefore, UCP1 is not
considered to be a signi¢cant regulator of human
energy expenditure.
UCP2, cloned recently as a second member of the
UCP family, is ubiquitously expressed in human and
rodent tissues including heart [6,7]. Another novel
member of the UCP family, UCP3, is preferentially
expressed in skeletal muscle and BAT [8^10]. Thus,
the new members, UCP2 and UCP3, are better suited
for regulated thermogenesis in large mammals in-
cluding humans. In contrast to rapidly emerging in-
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formation regarding synthesis and distribution, there
have been a few studies on developmental implica-
tions of UCP2 and UCP3 [11,12]. However, the
UCP2 gene has been reported to be expressed abun-
dantly in the heart [6,8,10,13], leaving its physiolog-
ical function in doubt.
By the 2nd week of the postnatal period, blood
£ow is changed from a fetal circulation pattern to
a postnatal one in which an increasing work load
on each ventricle results in a growing energy demand
on the heart [14,15]. In fact, carnitine palmitoyltrans-
ferase I isoforms in cardiac mitochondria are known
to change from a liver type to a muscle type in re-
sponse to increased energy demand during postnatal
development [16]. These ¢ndings led us to investigate
whether heart UCP2 gene expression may be altered
along with postnatal development and how the neo-
natal heart UCP2 expression is regulated.
To address these queries, we carried out the fol-
lowing studies. Firstly, on changes in gene expres-
sions of heart UCPs during rat postnatal develop-
ment. Secondly, we compared heart UCP2 mRNA
expression with BAT UCP1 mRNA during rat post-
natal development to determine whether heart UCP2
modulates thermogenetic activity similarly to BAT
UCP1. Finally, we aimed to examine possible factors
regulating rat heart UCP2 gene expression using cul-
tured neonatal cardiac myocytes free from the e¡ects
of neural and humoral control systems.
2. Materials and methods
2.1. Animals
Wistar King A postnatal rat pups were used for
developmental UCPs experiments. The dams were
housed in a room with lighting from 07:00 to
19:00 h (a 12:12 h light:dark cycle) and maintained
at 21 þ 1‡C with humidity at 55 þ 5%. They were al-
lowed free access to standard pelleted rat chow (CE-
2, CLEA Japan, Tokyo) and tap water.
2.2. Procedures
The heart and BAT were surgically removed under
ether anesthesia from four pups in each group con-
sisting of the 2nd day and the 1st, 2nd, 3rd and 4th
week of age. The tissue samples were immediately
frozen in liquid nitrogen and stored at 380‡C until
use for analysis of UCP mRNAs. In the study on
primary culture of cardiomyocytes, hearts taken
from neonates on the 3rd day after birth were
used. Cardiac myocytes were prepared by the modi-
¢ed Bollon’s method, as described elsewhere [17].
2.3. Cell culture
The hearts removed from the neonatal pups were
minced into 1-mm3 pieces. The pieces were incubated
in a 0.02% EDTA solution for 5 min at 37‡C with
shaking, and then in 5 ml of Hanks’ balanced salt
solution (HBSS) containing 3450 units collagenase
(type IV; Cooper Biochemical, Philadelphia, PA)
for 10 min in a 37‡C water bath shaker at 120
rpm. The supernatant was discarded and the remain-
ing pieces were treated with 5 ml of 1000 IU/ml Dis-
pase (Godo Shusei, Tokyo) in Ca2- and Mg2-free
HBSS using a magnetic stirrer for 20 min. The free-
£oating cardiac myocytes were centrifuged at 500Ug
for 5 min to collect the isolated cardiac myocytes.
The myocytes resuspended in Dulbecco’s modi¢ed
Eagle medium (DMEM) (Nissui pharmaceutical, To-
kyo) were seeded in plastic culture dishes and incu-
bated for 90 min at 37‡C in a CO2 incubator with a
gas phase of 5% CO2 in air to exclude ¢broblasts.
2U106 cells were planted in a 60-mm diameter cul-
ture dish containing 3 ml DMEM supplemented with
5% fetal bovine serum (Gibco Labs, Grand Island),
10 mmol/l HEPES and 100 IU kanamycin. After 48
h of culture to allow adherence of more than 70% of
the cells to the culture dishes, cells were maintained
in serum-free DMEM for 24 h. After this precondi-
tioning period, the cultures were incubated in serum-
free DMEM with the following agents or vehicles:
isoproterenol (ISP), a L-adrenoceptor agonist; phen-
ylephrine, an K-adrenoceptor agonist; and triiodo-
thyronine (T3) at concentrations of 1037, 1037 and
1038 M, respectively (Sigma Chemical, St. Louis,
MO for each).
2.4. Northern blot analysis
Total RNAs were extracted using ISOGEN (Nip-
pon Gene, Toyama) according to the manufacturer’s
protocol. Aliquots of 20 Wg total RNA were electro-
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phoresed on 1.2% formaldehyde-agarose gel, trans-
ferred onto a Biodyne B membrane (Pall Canada,
Mississauga, Ont.) in 20USSC solution by capillary
blotting, and immobilized by exposure to ultraviolet
light. Prehybridization and hybridization were car-
ried out as previously described [18], using the 32P-
labeled cDNA fragments of rat UCP1, UCP2 and
UCP3 as probes. Each cDNA probe was obtained
by RT-PCR on total RNA isolated from Wistar
King A rat BAT using oligonucleotide primers which
have the following sequence. UCP1-sense primer, 5P-
AGTGCCACTGTTGTCTTCAG-3P ; UCP1-anti-
sense primer, 5P-TTCTCCAAGTCGCCTATGTG-
3P ; UCP2-sense primer, 5P-CATCTTCTGGGAGG-
TAGC-3P ; UCP2-antisense primer, 5P-AAGA-
CAGGGCAGGAATGG-3P ; UCP3-sense primer,
5P-GTTACCTTTCCACTGGACAC-3P ; UCP3-anti-
sense primer, 5P-CCGTTTCAGCTGCTCATAGG-
3P. Membranes were washed with a solution of
2USSC/0.1% sodium dodecylsulfate (SDS) at room
temperature for 15 min and 1USSC/0.1% SDS at
42‡C for 15 min and 0.1USSC/0.1% SDS at 65‡C
for 15 min. After washing the membranes, the hy-
bridization signals were analyzed with a Bio-image
analyzer (BAS 2000, Fuji Film Institution, Tokyo).
The band intensities obtained by Northern blots were
normalized to those of 18S ribosomal RNAs.
2.5. Statistical analysis
Values in each experiment were expressed as the
mean þ S.E.M., unless otherwise speci¢ed. Develop-
mental changes in UCPs were analyzed by one-way
analysis of variance and Sche¡e¤’s F post hoc test.
Unpaired Student’s t-tests were used to assess the
e¡ects of drugs on UCP2 mRNA expression in cul-
tured cardiomyocytes. P values less than 0.05 were
de¢ned as statistically signi¢cant.
3. Results
3.1. Developmental alteration of UCPs mRNA
expression in the heart and BAT
As shown in Fig. 1, expression of UCP2 mRNA in
the heart was low on the 2nd neonatal day, but
gradually increased in the 1st postnatal week, and
then rapidly increased to reach a plateau in the 2nd
postnatal week. UCP2 expression at the plateau was
greater than that on the 2nd day and in the 1st week
by 207% and 108%, respectively (P6 0.05 for each).
The value in the 2nd week was sustained for the 3rd
and 4th weeks, in which the values were larger than
that on the 2nd day (P6 0.05 for each). Unlike the
expression of UCP2, UCP1 mRNA was undetectable
in the heart at any postnatal stage tested. Heart
UCP3 mRNA could not be detected until the 2nd
postnatal week, when expression became detectable
and was signi¢cantly greater than that in the 4th
postnatal week (P6 0.05) (Fig. 1).
Fig. 1. Developmental alterations of UCP2 and UCP3 mRNA
expression in the postnatal rat heart. (A) Representative North-
ern blots of the UCPs. Total RNAs (20 Wg/lane) in various
stages of life were used. (B) Time course alterations of the
UCPs. Hybridizations with UCP2 and UCP3 cDNA probes
were performed under the same condition. To quantify amounts
of mRNAs from the heart, the blots were reprobed with 18S
rRNA. Values and vertical bars, mean þ S.E.M. (n = 4).
*P6 0.05 vs. the 2nd postnatal day, **P6 0.05 vs. UCP3 in
the 2nd postnatal week. N, the 2nd postnatal day; 1, the 1st
postnatal week; 2, the 2nd postnatal week; 3, the 3rd postnatal
week; 4, the 4th postnatal week.
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UCP1 mRNA in BAT was abundantly expressed
on the 2nd postnatal day, but the value decreased
suddenly in the 1st postnatal week by 76%
(P6 0.05). The lower value in the 1st week was
maintained during the subsequent postnatal period,
as illustrated in Fig. 2. Expression of UCP2 and
UCP3 in BAT, similarly to UCP1, were greater in
the early postnatal period than later. UCP3 mRNA
decreased signi¢cantly in the 3rd and 4th postnatal
weeks by 78% and 63% respectively compared with
expression on the 2nd neonatal day (P6 0.05 for
Fig. 2. Developmental alterations of UCP1, UCP2 and UCP3
mRNA expression in the postnatal rat brown adipose tissue.
(A) Representative Northern blots of UCPs. Total RNAs (20
Wg/lane) in various stages of life were used. (B) Time course al-
terations of the UCPs. Hybridizations with UCP1, UCP2 and
UCP3 cDNA probes were performed under the same condition.
To quantify amounts of mRNAs from BAT, the blots were re-
probed with 18S rRNA. Values and vertical bars, mean þ
S.E.M. (n = 4). *P6 0.05 vs. the 2nd postnatal day. N, the 2nd
postnatal day; 1, the 1st postnatal week; 2, the 2nd postnatal
week; 3, the 3rd postnatal week; 4, the 4th postnatal week.
Fig. 3. E¡ects of isoproterenol (ISP), phenylephrine (Phe) and
triiodothyronine (T3) on UCP2 mRNA expression in neonatal
cultured cardiomyocytes. Di¡erences in loading were corrected
by normalization using the corresponding 18S rRNA values.
(A) Representative Northern blots of UCP2 after 24 h exposure
to 1037 M ISP (top panel), 1037 M Phe (middle panel), 1038
M T3 (bottom panel). (B) The quantitative representations of
the e¡ects of ISP and T3 on UCP2 mRNA in the cultured my-
ocytes. Each column (n = 4 for each), the value of UCP2
mRNA expression. *P6 0.05 vs. the corresponding controls.
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each), and UCP2 mRNA increased in the 1st post-
natal week by 82% compared with the 2nd neonatal
day (P6 0.05) (Fig. 2).
3.2. Adrenergic and hormonal e¡ects on UCP2
mRNA expression in cultured cardiac myocytes
To explore up-regulating modulators of the heart
UCP2 gene in the 2nd postnatal week, the e¡ects of
adrenoceptor agonists and T3 on UCP2 mRNA ex-
pression were examined in cultured neonatal cardiac
myocytes. Fig. 3 shows that UCP2 mRNA was in-
creased at 24 h after addition of 1037 M ISP
(P6 0.05), but not after 1037 M phenylephrine.
Akin to ISP, addition of 1038 M T3 up-regulated
UCP2 expression compared with the control
DMEM treatment (P6 0.05).
4. Discussion
In the present study, UCP2 gene expression in the
rat heart was predominantly up-regulated in the 2nd
postnatal week and maintained the increased value
throughout the experiment. In contrast to heart
UCP2, UCP1 gene expression in BAT was already
abundant on the 2nd day of the neonatal period.
UCP1 gene expression in mouse BAT has been re-
ported to reach to its peak at 15 h after birth, which
suggests that the up-regulation of the UCP1 gene
may be induced by thermal stress during transition
from an intrauterine to an extrauterine environment
[12]. The ¢ndings can be taken to indicate that the
present demonstration of up-regulated BAT UCP1 in
the neonatal period is consistent with mouse data,
and may be caused by the thermal stress, as well.
Up-regulation of the heart UCP2 gene, however, dif-
fered from that of BAT UCP1 in time to peak, while
the present results from UCPs mRNA remain to be
con¢rmed with Western blots. These ¢ndings indi-
cate that heart UCP2 up-regulation may be unrelated
to a sudden change in temperature of the environ-
ment. It can raise a question as to what mecha-
nism(s) is (are) involved in the up-regulation of heart
UCP2 gene expression in the postnatal period.
Recent reports showed that UCP2 and UCP3
mRNA expressions in skeletal muscle were up-regu-
lated in response to the increase of plasma fatty acids
levels [19,20]. Energy substrates used by the heart has
been known to change after the birth. In the fetal
and neonatal periods, the heart utilizes lactate and
glucose as its main energy substrates, while in the
adult, fatty acids are the main energy substrate.
This energy shift depends on the following factors.
First, increasing work load on the heart partly in-
duced by thyroid hormones and sympathetic inner-
vation. Second, changes of metabolic enzymes in-
volved in carbohydrate and fatty acid utilization.
Third, an increase in circulating fatty acids levels.
Fourth, maturation of mitochondrial processes in-
cluding activities of tricarboxylic acid cycle and elec-
tron transport chain enzymes [21]. These reports sug-
gest the possibility that UCP2 mRNA up-regulation
during development could be due to the increase of
fatty acids uptake into the heart. Fatty acid is known
to bind to peroxisome proliferator-activated receptor
(PPAR) as a potent ligand [22,23]. UCP1 gene has
been reported to contain PPAR response element
[24] and UCP2 is up-regulated by PPAR agonist in
white adipose tissue [25]. Taken together, it is likely
that fatty acids may work as a ligand for PPAR to
promote transcription of UCP2 in the postnatal rat
heart. In the present study, however, UCP2 was up-
regulated in response to T3 and ISP in serum free in
vitro experiments. The possible existence of thyroid
hormone response element and cAMP response ele-
ment in the UCP2 gene could provide the direct ef-
fect of T3 and ISP on transcription of UCP2. In fact,
thyroid hormones increase rapidly between the 8th
and the 15th postnatal days [26], and sympathetic
innervation of the heart becomes fully developed by
the 3rd week of the postnatal period [27,28]. As an-
other possibility, UCP2 could be associated with
apoptosis. UCP2 was reported to decrease generation
of hydrogen peroxide (H2O2) in mitochondria [29].
H2O2 has been found to induce apoptosis in the cul-
tured cardiomyocytes [30]. While direct evidence is
lacking at present, these data are compatible with
the possibility that UCP2 may play a crucial role
in protection against apoptosis during heart develop-
ment. In fact, apoptosis is active in the neonatal
period and decreases sharply by 21 postnatal days
[31].
In summary, developmental studies on UCPs gene
expression demonstrated that heart UCP2 gene ex-
pression increased to a peak in the 2nd postnatal
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week. Both ISP and T3 up-regulated heart UCP2
mRNA in neonatal cultured cardiomyocytes. These
results indicate that the sympathetic nervous system
and/or thyroid hormones could be involved in the
up-regulation of heart UCP2 gene expression during
postnatal development. The increase in postnatal
heart UCP2 may provide a key link between the
postnatal energy shift and adaptation of rat pups
to their novel environment.
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